Ki67 expression levels are a better marker of reduced melanoma growth following MEK inhibitor treatment than phospho-ERK levels
Keiran S.M. Smalley(Moffitt Cancer Center), Meenhard Herlyn(The Wistar Institute)
Cited by 105
Related Papers
A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade
|Cell|2018|1.5k
Colorectal carcinoma antigens detected by hybridoma antibodies
|Somatic Cell and Molecular Genetics|1979|1.4k
A Tumorigenic Subpopulation with Stem Cell Properties in Melanomas
|Cancer Research|2005|1.3k
High-throughput oncogene mutation profiling in human cancer
|Nature Genetics|2007|996
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma
|Nature Medicine|2018|813